Multicenter Trial to Treat Patients With Relapsed/Refractory Aggressive Non Hodgkin Lymphoma
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
This is a multicenter study to assess the anti-tumour activity,to investigate the safety
profile and to obtain additional pharmacokinetic information for Aplidin® given as 1-hour
weekly IV infusion in patients with aggressive non-Hodgkin's Lymphoma.